SomnoMed Limited (FRA:RJV)

Market Cap	40.00M -63.2%
Revenue (ttm)	69.35M +2.7%
Net Income	-1.60M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,600
Open	0.1770
Previous Close	0.1770
Day's Range	0.1770 - 0.1780
52-Week Range	0.1410 - 0.4920
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patien...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJV

Financial Performance

In fiscal year 2026, SomnoMed's revenue was 114.53 million, an increase of 2.73% compared to the previous year's 111.49 million. Losses were -2.65 million, -23.32% less than in 2025.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error